Cargando…
Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261295/ https://www.ncbi.nlm.nih.gov/pubmed/35822002 http://dx.doi.org/10.3389/fragi.2021.718966 |
| _version_ | 1784742241499086848 |
|---|---|
| author | Verschoor, Chris P. Haynes, Laura Pawelec, Graham Loeb, Mark Andrew, Melissa K. Kuchel, George A. McElhaney, Janet E. |
| author_facet | Verschoor, Chris P. Haynes, Laura Pawelec, Graham Loeb, Mark Andrew, Melissa K. Kuchel, George A. McElhaney, Janet E. |
| author_sort | Verschoor, Chris P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9261295 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92612952022-07-11 Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults Verschoor, Chris P. Haynes, Laura Pawelec, Graham Loeb, Mark Andrew, Melissa K. Kuchel, George A. McElhaney, Janet E. Front Aging Aging Frontiers Media S.A. 2021-06-25 /pmc/articles/PMC9261295/ /pubmed/35822002 http://dx.doi.org/10.3389/fragi.2021.718966 Text en Copyright © 2021 Verschoor, Haynes, Pawelec, Loeb, Andrew, Kuchel and McElhaney. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Aging Verschoor, Chris P. Haynes, Laura Pawelec, Graham Loeb, Mark Andrew, Melissa K. Kuchel, George A. McElhaney, Janet E. Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults |
| title | Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults |
| title_full | Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults |
| title_fullStr | Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults |
| title_full_unstemmed | Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults |
| title_short | Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults |
| title_sort | corrigendum: key determinants of cell-mediated immune responses: a randomized trial of high dose vs. standard dose split-virus influenza vaccine in older adults |
| topic | Aging |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261295/ https://www.ncbi.nlm.nih.gov/pubmed/35822002 http://dx.doi.org/10.3389/fragi.2021.718966 |
| work_keys_str_mv | AT verschoorchrisp corrigendumkeydeterminantsofcellmediatedimmuneresponsesarandomizedtrialofhighdosevsstandarddosesplitvirusinfluenzavaccineinolderadults AT hayneslaura corrigendumkeydeterminantsofcellmediatedimmuneresponsesarandomizedtrialofhighdosevsstandarddosesplitvirusinfluenzavaccineinolderadults AT pawelecgraham corrigendumkeydeterminantsofcellmediatedimmuneresponsesarandomizedtrialofhighdosevsstandarddosesplitvirusinfluenzavaccineinolderadults AT loebmark corrigendumkeydeterminantsofcellmediatedimmuneresponsesarandomizedtrialofhighdosevsstandarddosesplitvirusinfluenzavaccineinolderadults AT andrewmelissak corrigendumkeydeterminantsofcellmediatedimmuneresponsesarandomizedtrialofhighdosevsstandarddosesplitvirusinfluenzavaccineinolderadults AT kuchelgeorgea corrigendumkeydeterminantsofcellmediatedimmuneresponsesarandomizedtrialofhighdosevsstandarddosesplitvirusinfluenzavaccineinolderadults AT mcelhaneyjanete corrigendumkeydeterminantsofcellmediatedimmuneresponsesarandomizedtrialofhighdosevsstandarddosesplitvirusinfluenzavaccineinolderadults |